Natick, MA-based medical devices giant Boston Scientific (NYSE:[[ticker:BSX]]) said today that it has acquired Intelect Medical, a developer of neuromodulation technologies for deep brain stimulation. Boston Scientific, which already owned an equity stake in Intelect, is buying the firm for about $60 million in cash. Intelect’s technology is expected to complement Boston Scientific’s existing deep brain stimulation offerings and to enable physicians to visualize stimulation fields in the brain in order to provide more precise therapy. Deep brain stimulation, for example, has been used to treat patients with Parkinson’s disease.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
